Skip to main navigation
Skip to search
Skip to main content
Scholars @ UT Health San Antonio Home
Help & FAQ
English
Español
Home
Profiles
Research units
Publications
Datasets
Search by expertise, name or affiliation
Everolimus
Peter J. Houghton
Research output
:
Contribution to journal
›
Article
›
peer-review
188
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Everolimus'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Pharmacology, Toxicology and Pharmaceutical Science
Everolimus
100%
Renal Cell Carcinoma
33%
Neoplasm
16%
Vasculotropin Receptor
16%
Biological Marker
16%
Progression Free Survival
16%
Mammalian Target of Rapamycin
16%
Tumor Growth
16%
Antitumor Activity
16%
Protein Serine Threonine Kinase
16%
Tumor Regression
16%
Placebo
16%